MELANOMA BRIDGE

December 1st - 3rd, 2022

FACULTY

Sanjiv S. Agarwala

Professor of Hematology & Oncology, Temple University School of Medicine, Philadelphia, PA, US

Paolo A. Ascierto

Director of Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, National Cancer Institute “Fondazione G. Pascale”, Naples, Italy

Michael B. Atkins

Deputy Director & Professor, Acting Chief, Division of Hematology/Oncology, Georgetown University Medical School, Washington, DC, US

Allison Betof-Warner

Assistant Attending Physician, Melanoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, US

Christian Blank

Medical Oncology and Research Group Leader Tumor Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands

Corrado Caracò

Director of Melanoma and Skin Tumor Surgery, National Cancer Institute “Fondazione G. Pascale”, Naples, Italy

 

Richard D. Carvajal

Director of Experimental Therapeutics, Director of the Melanoma Service, Columbia University Medical Center, New York, NY, US

Sandra Demaria

Professor of Pathology and Laboratory Medicine, Professor of Radiation Oncology, Weill Cornell Medical College, New York, NY, US

Alexander M.M. Eggermont

Chief Scientific Officer, Board of Directors, Princess Máxima Center; Professor of Clinical&Translational Immunotherapy, Utrecht University, Utrecht, The Netherlands

Marc S. Ernstoff

Branch Chief, ImmunoOncology Branch (IOB), Developmental Therapeutics Program, Cancer Therapy & Diagnosis Division, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, US

Soldano Ferrone

Professor in Residence, Department of Surgery, Harvard Medical School; Immunologist, Department of Surgery, Massachusetts General Hospital, Boston, MA, US

Bernard A. Fox

Chief of Molecular and Tumor Immunology Laboratory, Robert W. Franz Cancer Research Center – Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, US

Thomas F. Gajewski

Professor of Medicine, Professor of Ben May Department of Cancer Research, Professor of Comprehensive Cancer Research Center, The University of Chicago Medical Center, Chicago, IL, US

Jerome Galon

Research Director, National Institute of Health and Medical Research (INSERM), Director, Integrative Cancer Immunology Team, Cordeliers Research Center, Paris, France

Claus Garbe

Professor of Dermatology, President of the European Association of DermatoOncology (EADO), Center for Dermatooncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany

Brian R. Gastman

Professor, Department of Surgery, School of Medicine, Member of Immune Oncology Program, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, US

Jeffrey E. Gershenwald

Professor of Cancer Biology, Departments of Surgical Oncology and Cancer Biology, Medical Director, Melanoma and Skin Center, The University of Texas, MD Anderson Cancer Center, Houston, TX, US

Omid Hamid

Chief of Research/ Immuno-Oncology, Co-Director, Cutaneous Malignancy Program, The Angeles Clinic and Research Institute, a Cedars Sinai Affiliate, Los Angeles, CA, US

Axel Hauschild

Professor of Dermatology, Department of Dermatology, University of Kiel, Kiel, Germany

Pawel Kalinski

SVP, Team Science, Chair, Department of Immunology, Professor of Oncology & Chief, Translational Immuno-Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, US

Michelle Krogsgaard

Associate Professor of Pathology, Co-leader of Tumor Immunology Program, Laura and Isaac Perlmutter Cancer Center, NYU Grossman School of Medicine, New York, NY, US

Roger S. Lo

Professor of Medicine/Dermatology, Associate Chief of Dermatology, Director of the Dermatology STAR Program, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, US

Jason J. Luke

Director, Immunotherapy and Drug Development Center, Associate Professor of Medicine, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, US

Francesco Marincola

Senior Vice President, Global Head of Cell Therapy Research, Kite Pharma, Santa Monica, CA, US

Giuseppe Masucci

Associate Professor, Department of Oncology-Pathology and KcRN, Karolinska Institutet, Cancer Centrum Karolinska (CCK), Karolinska University Hospital, Stockholm, Sweden

Janice M. Mehnert

Professor of Medicine, Associate Director for Clinical Research, Laura and Isaac Perlmutter Cancer Center, Director, Melanoma and Cutaneous Medical Oncology, NYU Grossman School of Medicine, New York, NY,US

Alexander Menzies

Medical Oncologist, Associate Professor of Melanoma Medical Oncology, The University of Sydney; Faculty Member, Melanoma Institute Australia; Chair, Department of Cancer Medicine, Mater Hospital; Chair, Melanoma and Skin Cancer Group, Clinical Oncology Society of Australia, Sydney, Australia

Olivier Michielin

Full Professor, Chair of Precision Oncology Center, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland

Nicola Normanno

Cell Biology and Biotherapy Unit, National Cancer Institute “Fondazione G. Pascale”, Naples, Italy

Iman Osman

Rudolf L. Baer MD Professor of Dermatology, Professor, Departments of Medicine (Oncology) and Urology, Director, Interdisciplinary Melanoma Program, Associate Dean for Translational Research Support, NYU Grossman School of Medicine, New York, NY, US

Giuseppe Palmieri

Full Professor of Medical Oncology, University of Sassari; Immuno-Oncology & Targeted Cancer Biotherapies, Sassari University Hospital; Associate Researcher, Head of Unit of Cancer Genetics, National Research Council (CNR); Head, Institute of Genetic & Biomedical Research (IRGB), Sassari, Italy

Michael A. Postow

Chief, Melanoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, US

Poulikos I. Poulikakos

Associate Professor, Department of Oncological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, US

Igor Puzanov

Senior Vice President, Clinical Investigation; Professor of Oncology and Medicine, Director of Center for Early Phase Clinical Trials Division, Chief, Melanoma Section, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, US

Sergio Quezada

Professor of Cancer Immunology and Immunotherapy, Immune Regulation & Tumour Immunotherapy Lab, CRUK Senior Cancer Research Fellow, UCL Cancer Institute, University College London, London, UK

Jeffrey A. Sosman

Professor of Medicine, Director, Melanoma program, Director, Faculty Development, Co-Leader, Translational Research in Solid Tumors, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Evanston, IL, US

Hussein A. Tawbi

Deputy Chair and Director of Personalized Cancer Therapy, Department of Melanoma Medical Oncology, Division of Cancer Medicine, Co-Director, MD Anderson Brain Metastasis Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX, US

Alessandro Testori

Chairman surgical subgroup, EORTC Melanoma Group, Brussels, Belgium

Magdalena Thurin

Program Director, Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, US

Jeffrey S. Weber

Deputy Director, Laura and Isaac Perlmutter Cancer Center, Professor of Oncology, Department of Medicine, NYU Grossman School of Medicine, New York, NY, US

Laurence Zitvogel

Group Leader of Tumour immunology and immunotherapy of cancer, Gustave Roussy Institute, National Institute of Health and Medical Research (INSERM), Villejuif, France